AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metfotia-G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Querencia Healthcare Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metfotia-G1 Tablet SR

GlucoDuo-XR, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combination therapy regulates blood glucose. GlucoDuo-XR should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glucose levels. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and trembling, and carry readily available glucose like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver impairment. Inform your physician of any history of heart disease before starting treatment; it may be unsuitable. Pregnant or nursing individuals should consult their doctor. Regular blood glucose monitoring is essential, along with periodic blood tests to check blood cell counts and liver function.

Uses of Metfotia-G1 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Metfotia-G1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Metfotia-G1 Tablet SR with a meal.

Common Side effects of Metfotia-G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metfotia-G1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfotia-G1 Tablet SR should be administered with a meal.

How Metfotia-G1 Tablet SR works:

Metformin and Glimepiride, combined in Metfotia-G1 SR tablets, offer a dual approach to blood sugar management. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts through multiple mechanisms: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metfotia-G1 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Metfotia-G1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Metfotia-G1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Metfotia-G1 SR tablets; dosage modification may be necessary. Consult a physician for guidance. Metfotia-G1 SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metfotia-G1 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose of Metfotia-G1 Tablet SR is typically prescribed for individuals with mild to moderate hepatic dysfunction; its use is contraindicated in those with severe liver disease.

What if you forget to take Metfotia-G1 Tablet SR :

Should you forget a Metfotia-G1 Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metfotia-G1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metfotia-G1 Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Metfotia-G1 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Metfotia-G1 Tablet SR and seek immediate medical attention.
Metfotia-G1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Metfotia-G1 Tablet SR may cause common side effects such as low blood sugar, taste changes, nausea, stomach upset, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metfotia-G1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Metfotia-G1 Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metfotia-G1 Tablet SR and alcohol is unsafe. Alcohol consumption may exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Metfotia-G1 Tablet SR
31
MRP 38
18% off